AMLI (The Association of Medical Laboratory Immunologists), Pittsburgh PA, Corgenix promotes their expanded line of Auto Immune tests.
At the 2016 AACC Clinical Lab Expo August 2-4, Philadelphia PA, Corgenix and ORGENTEC company combined to exhibit their unique brand of products. ORGENTEC, a global specialty diagnostic company, highlighting its broad menu of more than 350 diagnostic tests including autoimmune, cardiovascular, infectious diseases and organ function assays. The Alegria® Analyzer is trusted in more than 1,000 placements around the world to improve lab accuracy and productivity while increasing flexibility in rare-disease testing, even for small labs. CORGENIX, a unique brand of quality and highlighting their autoimmune and cardiovascular offerings, including the AspirinWorks® test, the world’s only urine test for measuring thromboxane metabolites to determine aspirin effect. CORGENIX is also recognized as a superior partner in the industry for its contract R&D and contract manufacturing services and would welcome inquiries about its capabilities.
Miami, Fl. Baptist Heatlh South Florida presents the 14th Annual Cardiovascular Disease Prevention Annual International Symposium and Miami Cardiac & Vascular Institute Cardiovascular Summit. Corgenix highlights their AspirinWorks® test, the world’s only urine test for measuring thromboxane metabolites to determine aspirin effect.
Publication in Reviews in Cardiovascular Medicine, Neath S-X et al. “The Current and Future Landscape of Urinary Thromboxane Testing to Evaluate Atherothrombotic Risk”. 2014, 15:2; 119-130. “….testing UTxB2 levels is an appropriate first step for identifying individuals at increased risk for downstream atherothrombotic events associated with cardiovascular disease.”